Psychogenetic, genetic and epigenetic mechanisms in Candida auris: Role in drug resistance

Affiliations

01 February 2023

-

doi: 10.1016/j.jiph.2022.12.012


Abstract

In recent years, we are facing the challenge of drug resistance emergence in fungi. The availability of limited antifungals and development of multi-drug resistance in fungal pathogens has become a serious concern in the past years in the health sector. Although several cellular, molecular, and genetic mechanisms have been proposed to explain the drug resistance mechanism in fungi, but a complete understanding of the molecular and genetic mechanisms is still lacking. Besides the genetic mechanism, epigenetic mechanisms are pivotal in the fungal lifecycle and disease biology. However, very little is understood about the role of epigenetic mechanisms in the emergence of multi-drug resistance in fungi, especially in Candida auris (C. auris). The current narrative review summaries the clinical characteristics, genomic organization, and molecular/genetic/epigenetic mechanisms underlying the emergence of drug resistance in C. auris. A very few studies have attempted to evaluate the role of epigenetic mechanisms in C. auris. Furthermore, advanced genetic tools such as the CRISP-Cas9 system can be utilized to elucidate the epigenetic mechanisms and their role in the emergence of multi-drug resistance in C. auris.

Keywords: Candida auris; Drug resistance; Epigenetic; Fungi; Genetic.


Similar articles

On Fruits and Fungi: A Risk of Antifungal Usage in Food Storage and Distribution in Driving Drug Resistance in Candida auris.

Yadav V, Heitman J.mBio. 2022 Jun 28;13(3):e0073922. doi: 10.1128/mbio.00739-22. Epub 2022 May 16.PMID: 35575501 Free PMC article.

The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris.

Rybak JM, Cuomo CA, Rogers PD.Curr Opin Microbiol. 2022 Dec;70:102208. doi: 10.1016/j.mib.2022.102208. Epub 2022 Oct 12.PMID: 36242897 Review.

Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance In Vitro and In Vivo.

Burrack LS, Todd RT, Soisangwan N, Wiederhold NP, Selmecki A.mBio. 2022 Aug 30;13(4):e0084222. doi: 10.1128/mbio.00842-22. Epub 2022 Jul 5.PMID: 35862787 Free PMC article.

Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris.

Rybak JM, Muñoz JF, Barker KS, Parker JE, Esquivel BD, Berkow EL, Lockhart SR, Gade L, Palmer GE, White TC, Kelly SL, Cuomo CA, Rogers PD.mBio. 2020 May 12;11(3):e00365-20. doi: 10.1128/mBio.00365-20.PMID: 32398311 Free PMC article.

Candida auris: Epidemiology, biology, antifungal resistance, and virulence.

Du H, Bing J, Hu T, Ennis CL, Nobile CJ, Huang G.PLoS Pathog. 2020 Oct 22;16(10):e1008921. doi: 10.1371/journal.ppat.1008921. eCollection 2020 Oct.PMID: 33091071 Free PMC article. Review.


Cited by

Antifungal Drug Resistance: An Emergent Health Threat.

Vitiello A, Ferrara F, Boccellino M, Ponzo A, Cimmino C, Comberiati E, Zovi A, Clemente S, Sabbatucci M.Biomedicines. 2023 Mar 31;11(4):1063. doi: 10.3390/biomedicines11041063.PMID: 37189681 Free PMC article. Review.


KMEL References